Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Laxmi Organic Industries Ltd Performance

Today's Low
252.70
arrowIcon
Today's High
266.35
52 Wk Low
221.80
arrowIcon
52 Wk High
320.95


Open

254.2

Traded Value (Cr)

78.96 Cr

Prev. Close

254.65

VWAP

261.63

Volume

23,86,840

Face Value

2

Laxmi Organic Industries Ltd Fundamentals

Market Cap
₹ 7,020 Cr
P/E Ratio (TTM)
69.74
P/B Ratio
4.09
Debt to Equity
0.12
ROE
6.90 %
EPS (TTM)
3.65
Dividend Yield
0.19%
Book Value
62.29

Click here to know more about Fundamentals

Laxmi Organic Industries Ltd Financials

Laxmi Organic Industries Ltd Financials

Laxmi Organic Industries Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 69.72 % 69.83 % 72.39 % 72.39 %
Retail 22.35 % 22.27 % 22.01 % 21.89 %
Others 4.16 % 4.14 % 3.71 % 3.83 %
Mutual Funds 2.92 % 3.09 % 1.41 % 1.40 %
FII 0.85 % 0.67 % 0.48 % 0.48 %

Promoters

69.72%

Retail

22.35%

Others

4.16%

Mutual Funds

2.92%

FII

0.85%

Promoters

69.83%

Retail

22.27%

Others

4.14%

Mutual Funds

3.09%

FII

0.67%

Promoters

72.39%

Retail

22.01%

Others

3.71%

Mutual Funds

1.41%

FII

0.48%

Promoters

72.39%

Retail

21.89%

Others

3.83%

Mutual Funds

1.40%

FII

0.48%

Resistance and Support

₹255.05

PIVOT

resistance-arrow
Resistance
First Resistance₹263.050
Second Resistance₹271.450
Third Resistance₹279.450
support-arrow
Support
First Resistance₹246.650
Second Resistance₹238.650
Third Resistance₹230.250
RSI72.716
MACD9.850
ADX20.633
CCI131.100

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day2,386,8401,031,47333.86
Week1,032,461545,11239.20
1 Month1,833,915487,31940.15
6 Months2,386,840735,82330.83

About Laxmi Organic Industries Ltd

Laxmi Organic Industries Limited (LOIL) is the Goenka Group's flagship company, established in 1989 and is in the business of acetyl intermediates and specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by LOIL from Clariant Chemicals India Limited. Laxmi Organic Industries Limited was incorporated on May 15, 1989. The Company is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates with almost three decades of experience in large scale manufacturing of chemicals. Since its inception in 1989, the company has been on a journey of transformation. The Company initially started manufacturing acetaldehyde and acetic acid in 1992, and soon thereafter moved on to manufacturing of ethyl acetate in 1996. The Company is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market. Further, post completion of the YCPL Acquisition, the market share in the ethyl acetate market will be further enhanced. In 2010, the company commenced manufacturing the Specialty Intermediates by acquiring Clariant's diketene business. The Company believes that the diversification of its product portfolio into varied chemistries in Specialty Intermediates has enabled it to create a niche for itself. The Company is the only manufacturer of diketene derivatives in India with a market share of approximately 55 % of the Indian diketene derivatives market in terms of revenue in Fiscal 2020 and one of the largest portfolios of diketene products. The Company's products are currently divided into two broad categories, namely the Acetyl Intermediates and the Specialty Intermediates. The Acetyl Intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol and other proprietary solvents, while the Specialty Intermediates comprises of ketene, diketene derivatives namely esters, acetic anhydride, amides, arylides and other chemicals. These products find application in various high-growth industries, including pharmaceuticals, agrochemicals, dyes & pigments, inks & coatings, paints, printing & packaging, flavours & fragrances, adhesives and other industrial applications. The Company also proposes to diversify into manufacturing of specialty fluorochemicals to which end, the company has recently acquired assets including plant & machinery, design and operating paperwork, REACH registrations and patents of Miteni, a manufacturer of organic fluorospecialties and electrochemical fluorination. The Company believes it is well placed to enter into the high margin specialty fluorochemicals space through this acquisition. According to the Frost & Sullivan Report, given its expertise in the Acetyl Intermediates and the Specialty Intermediates segments, its entry into the fluorochemicals space will put the company at a differentiated position from other chemicals manufacturers. Over the years, the company has significantly expanded its scale of operations and global footprint with customers in over 30 countries including China, Netherlands, Russia, Singapore, United Arab Emirates, United Kingdom and United States of America. The Company has established long-standing relationships with marquee players including Syngenta Asia Pacific Pte. Ltd., Alembic Pharmaceuticals Limited, Covestro (India) Private Limited, Dr. Reddy's Laboratories Limited, Flint Group India Private Limited, Granules India Limited, Hetero Labs Limited, Heubach Colour Private Limited, Hubergroup India Private Limited, Huhtamaki India Limited, Laurus Labs Limited, Macleods Pharmaceuticals Private Limited, Mylan Laboratories Limited, Neuland Laboratories Limited, Parikh Packaging Private Limited, Suven Pharmaceuticals Limited, Colourtex Industries Private Limited, and UPL Limited. The Company has offices in Leiden (Netherlands), Shanghai (China) and Sharjah (United Arab Emirates) which enables it to assess international demand and increase its customer outreach thereby bolstering its product development initiatives. The Company also has arrangements with third parties for usage of storage tanks in inter alia Mumbai for storage of raw materials and finished goods and Rotterdam (Netherlands), Antwerp (Belgium) and Genoa (Italy) for storage of finished products which enables the company to deliver its products on short notice. The Company has been the largest exporter of ethyl acetate from India in the six months ended September 30, 2020 and Fiscals 2020, 2019 and 2018 and one of the largest exporters of ethyl acetate to Europe from India since 2012. The Company currently has two manufacturing facilities in Mahad, Maharashtra with one facility dedicated to Acetyl Intermediates and another dedicated to Specialty Intermediates, which are strategically located in proximity to several ports and each other. As at September 30, 2020, the aggregate installed production capacity at the AI Manufacturing Facility was 161,320 MTPA, while the aggregate installed production capacity at the SI Manufacturing Facility was 78,045 MTPA. The Company is also in the process of acquiring YCPL, having an aggregate installed production capacity of 10,500 MTPA of acetaldehyde and 29,200 MTPA of ethyl acetate as on September 30, 2020. The Company also has two distilleries located in Satara district (the Jarandeshwar Distillery) and Kolhapur district in Maharashtra (the Panchganga Distillery and together with the Jarandeshwar Distillery) for the manufacturing of ethanol or specially denatured spirit. As at September 30, 2020, the Jarandeshwar Distillery had an installed production capacity of 8,100 KLPA while the Panchganga Distillery had an installed production capacity of 9,112 KLPA. The ethanol manufactured at the Distilleries is primarily consumed at the AI Manufacturing Facility and the SI Manufacturing Facility for the manufacturing of fuel-grade ethanol, ethyl acetate and certain Specialty Intermediates including several downstream products. Further, the company is in the process of setting up a manufacturing facility at Lote Parshuram, Maharashtra for manufacturing fluorospecialty chemicals. The Company has 2 Department of Scientific and Industrial Research, Government of India (DSIR) recognized research and development facilities, with infrastructure to synthesize specialty molecules and advanced intermediates. During the year 2018-19, the Hydro Power Project at Yedgaon got commissioned and the power generation for captive consumption was also started. During the year 2018-19, the Company sold 49% of the total equity shares which it held in Suvas Holdings Limited to Mr. Ravi Goenka and Mr. Rajeev Goenka. Hence, Suvas Holdings Limited is no longer an associate / joint-venture of the Company. During year 2019-20, the Company incorporated its wholly owned subsidiary (WOS), Laxmi Speciality Chemicals (Shanghai) Co. Limited in China on September 5, 2019. It also incorporated 2 new WOS in India, namely Yellowstone Fine Chemicals Private Limited and Yellowstone Speciality Chemicals Private Limited. During the year 2020-21, Company came out with and Initial Public Offering (IPO) aggregating to Rs. 8,000 million out of which Rs. 2,000 million was issued as Pre-IPO placements to marquee investors such as IIFL, GMO, WhiteOak, Malabar and Kuber India. The offer was subscribed and eventually, the Company was listed on The National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on March 25, 2021. During the year 2021-22, Company acquired 100% equity share capital of Acetyls Holding Private Limited (AHPL) through Share Purchase Agreement dated December 09, 2020 and Prospectus dated March 18, 2021 and accordingly, with this acquisition, AHPL and its wholly owned subsidiary Company, Yellowstone Chemicals Private Limited (YCPL) became subsidiaries of Company w.e.f. October 01, 2021. During the year 2022-23, the wholly owned subsidiary namely, Acetyls Holding Private Limited (AHPL) and its step-down subsidiary namely, Yellowstone Chemicals Private Limited (YCPL), merged with the Company and accordingly, the Assets and Liabilities of the amalgamating entities got incorporated to and vested in the Laxmi Organic Industries Ltd. (LOIL / the Parent Company) effective from September 30, 2022.

Managing Director

Ravi Goenka

Founded

1989

NSE Symbol

LXCHEM

Laxmi Organic Industries Ltd Management

NameDesignation
Ravi GoenkaChairman & Managing Director
Satej NabarExecutive Director & CEO
Harshvardhan GoenkaExecutive Director
Rajeev GoenkaNon Executive Director
Manish ChokhaniIndependent Director
O V BundelluIndependent Director
Sangeeta SinghIndependent Director
Rajeev VaidyaIndependent Director
Aniket HirparaCompany Sec. & Compli. Officer
Rajiv BanavaliIndependent Director

Laxmi Organic Industries Ltd News

Volumes spurt at Laxmi Organic Industries Ltd counter
Laxmi Organic Industries Ltd registered volume of 124.81 lakh shares by 14:14 IST on NSE, a 18.65 fold spurt over two-week average daily volume of 6.69 lakh shares
Laxmi Organic Industries consolidated net profit declines 0.15% in the December 2023 quarter
Sales rise 6.06% to Rs 694.30 crore
Laxmi Organic Industries schedules board meeting
On 24 January 2024
Laxmi Organic gains as PAT rises by 25% YoY in Q2 FY24
Laxmi Organic Industries rose 1.31% to Rs 255 after specialty chemical maker's consolidated net profit increased 24.5% to Rs 10.71 crore in Q2 FY24 as against Rs 8.60 crore in Q2 FY23.
Laxmi Organic Industries consolidated net profit rises 24.53% in the September 2023 quarter
Sales rise 0.01% to Rs 652.27 crore
Laxmi Organic Industries announces board meeting date
On 26 October 2023
Laxmi Organic Industries Ltd leads losers in 'A' group
TD Power Systems Ltd, Jaiprakash Associates Ltd, Tech Mahindra Ltd and Mishra Dhatu Nigam Ltd are among the other losers in the BSE's 'A' group today, 12 October 2023.
Volumes jump at Laxmi Organic Industries Ltd counter
Laxmi Organic Industries Ltd saw volume of 181.88 lakh shares by 14:14 IST on NSE, a 42.67 fold spurt over two-week average daily volume of 4.26 lakh shares
Laxmi Organic jumps on completing Rs 259-cr QIP issue
Laxmi Organic Industries surged 8.35% to Rs 293.80 after the specialty chemicals maker announced the successful conclusion of its qualified institutions placement (QIP) for the company's equity shares.
Laxmi Organic issues commercial papers worth Rs 50 crore
The chemical company informed that it has issued commercial papers (CPs) of Rs 50 crore on 6 October 2023 in favor of Kotak Mahindra Bank.

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
PIDILITIND₹ 1,51,863 Cr
₹ 2,985.85
(-0.47 %)
87.47
SRF₹ 78,027 Cr
₹ 2,632.30
(-0.50 %)
51.40
LINDEINDIA₹ 57,947 Cr
₹ 6,795.00
(-2.42 %)
137.79
FLUOROCHEM₹ 39,358 Cr
₹ 3,582.95
(3.06 %)
57.07
DEEPAKNTR₹ 31,598 Cr
₹ 2,316.70
(0.85 %)
75.43

Laxmi Organic Industries Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Laxmi Organic Industries Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Laxmi Organic Industries Ltd's share price is ₹259.20 as of April 12, 2024

Laxmi Organic Industries Ltd's P/E ratio is 69.74 times as of April 12, 2024.

Laxmi Organic Industries Ltd's most recent financial reports indicate a price-to-book ratio of 4.09, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Laxmi Organic Industries Ltd's market is 7,020 Cr as on April 12, 2024.

The current financial records of Laxmi Organic Industries Ltd show a 6.90% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Laxmi Organic Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Laxmi Organic Industries Ltd's 52-week high and low as of April 12, 2024 are ₹266.35 and ₹252.7 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Laxmi Organic Industries Ltd stands at 69.72%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.67% to 0.85%.